Printer Friendly

AMGEN ANNOUNCES STOCK REPURCHASE PROGRAM

 AMGEN ANNOUNCES STOCK REPURCHASE PROGRAM
 THOUSAND OAKS, Calif., Feb. 25 /PRNewswire/ -- Amgen (NASDAQ: AMGN)


today announced a common stock repurchase program to purchase up to $50 million of common stock before Jan. 31, 1993. The purchases made under this program will satisfy a portion of the company's obligations under the company's existing employee benefit Stock Option Plans and its 423(b) Employee Stock Purchase Plan. Purchases of the company's common stock will be made on the open market from time to time in compliance with Rule 10 b-18 of the Securities Exchange Act of 1934.
 Amgen Inc. is a pharmaceutical company that develops, manufactures and markets human pharmaceuticals based on advanced cellular and molecular biology.
 -0- 2/25/92
 /CONTACT: Sarah H. Crampton (investors), 805-499-5725, ext. 3250, or Kimberly L. Dorsey (media), 805-499-5725, ext. 4367, both of Amgen/
 (AMGN) CO: Amgen Inc. ST: California IN: MTC SU:


JL -- LA038 -- 2554 02/25/92 17:11 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 25, 1992
Words:156
Previous Article:FARRAGUT MORTGAGE CO. ANNOUNCES PUBLIC OFFERING
Next Article:CONTINUUM ANNOUNCES COGEN LICENSE IN EUROPE
Topics:


Related Articles
IN BRIEF.
AMGEN INCOME BEATS FORECAST.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters